MarketInOut Stock Screener Log In | Sign Up
 

Purple Biotech Ltd ADR

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Purple Biotech Ltd ADR stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1.76 mln
Float1.62 mln
Earnings Date11/13/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

14 / 100
Significantly lagging

Debt / Equity

0.01
Debt-free

ROE

-127
Deeply negative

ROA

-103
Deeply negative

Business Description

Purple Biotech Ltd. is an Israel-based clinical-stage biopharmaceutical company working to help cancer patients whose tumors resist treatment or evade the immune system. The company is advancing several experimental therapies, including two drugs currently in Phase 2 trials targeting pancreatic cancer, head and neck cancer, and colorectal cancer, as well as an early-stage program aimed at stimulating the immune system to attack tumors. Purple Biotech works alongside Bristol Myers Squibb to test one of its key treatments in combination with a widely used immunotherapy drug.

Key Fundamentals

EPS-47.64
ROE-127
ROIC-40.01
ROA-103
Interest Cover-116
EBITDA, mln-23.48
EV / EBITDA-0.04
EV / EBIT-0.04

Quote Details

Last 1.08
Change 0.03 (2.86%)
Open 1.03
Volume 23,631
Turnover 25,521
Average Volume 22,704

Financial Ratios

Leverage Ratio1.15
Current Ratio3.70
Price / Book0.97
Debt / Equity0.01

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio0.01
Short % of Float1.11

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.26% 16 / 100   
1 Month -27.03% 13 / 100   
2 Months -25.52% 19 / 100   
6 Months -76.21% 5 / 100   
1 Year -81.48% 8 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog